International appetite for investment in Scotland’s life sciences sector remains robust, according to industry experts, boding well for the year ahead despite wider economic difficulties.
The push for solutions to support a growing and ageing population was already driving interest in food and health research prior to the Covid pandemic, which unleashed a further wave of cash for scientific innovation. Investors are also increasingly hunting for greener holdings to put in their portfolios, giving Scotland’s burgeoning industrial biotech sector added allure.
From meat grown in a laboratory to new treatments for cancer, Scotland’s universities have a strong track record in life sciences across a range of disciplines within the sector. Young spin-out companies have access to dozens of local sources of early-stage funding, but overseas investment remains vital for most if they are to grow to significant size.
** Click here to read the full-text **
